Market Place
Sourcing Support
BMS Removes 2 Clinical Programs From Pipeline
30 Oct 2025 //
FIERCE BIOTECH
Bristol Myers Squibb Unveils Q3 2025 Financial Results
30 Oct 2025 //
BUSINESSWIRE
Cobenfy Delivers OK Debut Year As BMS Works To Ease Nerves
30 Oct 2025 //
FIERCE PHARMA
Enforcement Report - Week of October 29, 2025
29 Oct 2025 //
FDA
BMS, Cabaletta`s CAR T Therapy Shows Promise In Small Lupus Study
28 Oct 2025 //
BIOSPACE
Evotec Announces Preclinical Neuroscience Partnership with BMS
27 Oct 2025 //
PHARMIWEB
BMS Shows Sotyktu Efficacy In Psoriatic Arthritis & Lupus
27 Oct 2025 //
BUSINESS WIRE
Maplight Goes Public Via $250M IPO To Fund Cobenfy Competitor
27 Oct 2025 //
FIERCE BIOTECH
BMS Ph1 Breakfree-1 Data Show Promise for CD19 NEXT CAR T Therapy
25 Oct 2025 //
BUSINESSWIRE
Replimune`s Stock Spikes 100% On FDA Acceptance Of Resubmission
20 Oct 2025 //
FIERCE BIOTECH
Systimmune, Bristol Myers Squibb Unveil Global Phase I Results
17 Oct 2025 //
PR NEWSWIRE
Deck Bio And ReTrax Therapeutics Win 2025 BMS Golden Tickets
15 Oct 2025 //
PR NEWSWIRE
Insitro Extends Research Collab with BMS via ChemML Platform
14 Oct 2025 //
BUSINESSWIRE
Bristol Myers Squibb Highlights Oncology Innovations At ESMO 2025
14 Oct 2025 //
INDPHARMAPOST
Bristol Myers Squibb To Showcase Oncology Portfolio Progress
13 Oct 2025 //
BUSINESSWIRE
Bristol Myers Squibb launches Kopozgo (Mavacamten) in India
13 Oct 2025 //
EXPRESSPHARMA
BMS Cooks Up Schizophrenia Stigma-Busting Push With Gail Simmons
13 Oct 2025 //
FIERCE PHARMA
Ono`s BMS-Partnered IO Drug Passes Phase 2 Gastric Cancer Test
11 Oct 2025 //
FIERCE BIOTECH
BMS & Gail Launch Initiative to Reduce Schizophrenia Stigma
10 Oct 2025 //
BUSINESSWIRE
BMS Inks $1.5B Deal To Pull Orbital Into Its Sphere Of Influence
10 Oct 2025 //
PRESS RELEASE
Maplight Illuminates $262M IPO Plans To Fund Cobenfy Competitor
07 Oct 2025 //
FIERCE BIOTECH
BMS`s Anti-MTBR-Tau Receives Fast Track designation For Alzheimer
05 Oct 2025 //
INDPHARMAPOST
Bristol Myers`s BMS-986446 Receives FDA Fast Track Designation
01 Oct 2025 //
BUSINESSWIRE
Bristol Myers Squibb Secures FDA Fast Track For BMS-986446
01 Oct 2025 //
BUSINESSWIRE
Bms, Takeda Join Peers In Push To Improve AI By Pooling Data
01 Oct 2025 //
FIERCE BIOTECH
BMS Launches Patient Connect, Expands Access to Sotyktu
30 Sep 2025 //
INDPHARMAPOST
BMS Expands Patient Connect Platform With Eliquis And Sotyktu
25 Sep 2025 //
BUSINESSWIRE
BMS Puts Discounted Sotyktu At The Center Of Next DTC Platform
25 Sep 2025 //
FIERCE PHARMA
Systimmune To Showcase Data On Izalontamab Brengitecan & BL-M07D1
24 Sep 2025 //
PR NEWSWIRE
BMS Midtrial Endpoint Addition Secures Phase 3 Win in Myeloma
24 Sep 2025 //
FIERCE BIOTECH
BMS Will Charge Same Price In Uk As Its Does In Us For Cobenfy
22 Sep 2025 //
FIERCE PHARMA
Bristol Myers Squibb to Report Q3 2025 Results on Oct 30, 2025
19 Sep 2025 //
BUSINESSWIRE
Novo, BMS Layoffs Leave Over 500 Jobless in New Jersey
18 Sep 2025 //
BIOSPACE
6 Pharma Layoffs Could Eliminate Over 39,000 Jobs
18 Sep 2025 //
BIOSPACE
Bristol Myers Squibb Announces Dividend
17 Sep 2025 //
BUSINESSWIRE
NJ layoffs: Novo Nordisk dismisses 263, BMS cuts 282 workers
17 Sep 2025 //
FIERCE PHARMA
FDA approves Lupin`s Lenalidomide capsules
17 Sep 2025 //
INDPHARMAPOST
J&J`s IL-23 Drug Defeats Sotyktu in Phase 3 Psoriasis Trial
17 Sep 2025 //
PR NEWSWIRE
FDA Issues Over 100 Warnings in Ad Crackdown
16 Sep 2025 //
RAPS
BMS Sells Majority Stake in Historic US-China Pharmaceutical JV
16 Sep 2025 //
FIERCE PHARMA
Biocartis NV Gets FDA Approval for Idylla™ CDx MSI Test
15 Sep 2025 //
GLOBENEWSWIRE
Novartis Falls in Another IRA Price Negotiation Loss for Pharma
12 Sep 2025 //
FIERCE PHARMA
BioNTech, BMS Tout First Global Data for Pd-L1x Vegf Bispecific
09 Sep 2025 //
PRESS RELEASE
Braveheart Pays $65 M to Challenge BMS for Heart Disease Market
05 Sep 2025 //
FIERCE BIOTECH
Bristol Myers Squibb Showcases Camzyos Real-World Results at ESC
29 Aug 2025 //
PHARMAWEB
Bristol Myers Squibb to Unveil Clinical Data at ESC Congress 2025
25 Aug 2025 //
PHARMAWEB
FDA Approves Agilent MMR IHC Panel for Colorectal Cancer
20 Aug 2025 //
BUSINESSWIRE
U.S. FDA grants Breakthrough Therapy for Izalontamab Brengitecan
18 Aug 2025 //
PR NEWSWIRE
BMS’ Breyanzi Accepted for Review in Marginal Zone Lymphoma
04 Aug 2025 //
BUSINESSWIRE
Bristol Myers Squibb`s Q2 2025 Financial Results Released
31 Jul 2025 //
BUSINESSWIRE
BMS Highlights Commercial Success Amid Clinical Setbacks
31 Jul 2025 //
FIERCE BIOTECH
BMS` Cobenfy Future Uncertain After Phase III Failure
31 Jul 2025 //
BIOSPACE
Bristol Myers, Bain form New Company to Develop Immunology Drug
29 Jul 2025 //
REUTERS
Bristol Myers Squibb Appoints New Evp, Chief Medical Officer
25 Jul 2025 //
CONTRACTPHARMA
BMS`s sNDA for Sotyktu in Psoriatic Arthritis Under Review
21 Jul 2025 //
BUSINESSWIRE
BMS` Anemia Drug Reblozyl Flunks Phase III Myelofibrosis Trial
19 Jul 2025 //
BIOSPACE
BMS, Pfizer offer Eliquis to patients at 40% below list price
18 Jul 2025 //
FIERCE PHARMA
BioNTech`s Chief Strategy Officer Heads for The Exit
17 Jul 2025 //
FIERCE BIOTECH
BMS Opens RayzeBio Radiopharma Production Site in Indianapolis
15 Jul 2025 //
FIERCE PHARMA
Onco360 named national specialty pharmacy for Augtyro
07 Jul 2025 //
GLOBENEWSWIRE
